In October of 2011 Dr. Lekki Frazier-Wood was elected to the editorial board of Psychological Medicine. This is in recognition of her unique expertise in genetic modeling, and her extensive participation in assessing the scientific validity of potential contributions to the journal. Psychological Medicine has a 2010 impact factor of 5.2, making it ranked 5th in the 'Clinical Psychology' and 11th in the 'Psychiatry' Thompson Reuters categories.
Dr. Frazier-Wood’s PhD training involved modeling the gene-environment interplay underlying cognitive performance and activity levels, as candidate biomarkers for Attention Deficit/Hyperactivity Disorder. For her postdoctoral training she has extended this to the analysis of lipoprotein diameters, as a marker of insulin resistance, and is involved in identifying the genetic variants and environmental influences that contribute to variations in diameter. Dr. Frazier-Wood aims to extend this analysis by looking how diet and exercise can change lipoprotein diameters, and whether this may operate through their effects on gene expression. She hopes this will eventually lead to more effective treatment strategies that reduce the progression of insulin resistance through type 2 diabetes to cardiovascular disease.